George Boubouras from K2 Asset Management highlights "U.S. dollar risk" as one of the key reasons why he underweights emerging markets broadly going into 2025.
Sumeet Bagadia recommends five shares to buy today — RPG Life Sciences, Platinum Industries, Bajaj Healthcare, Jubilant Ingrevia, and Hilton Metal Forging.
Some results have been hidden because they may be inaccessible to you